Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Everolimus + Chemotherapy in TNBC
NCT00499603Phase 2Unknown
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2007
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in triple-negative breast cancer (TNBC), sponsored by University of Texas MD Anderson Cancer Center. Status: unknown.
02
Drugs
everolimus
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT00499603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499603.